Literature DB >> 24252701

Vaccination of cattle with a recombinant bivalent toxoid against botulism serotypes C and D.

Carlos E P Cunha1, Gustavo M S G Moreira1, Felipe M Salvarani2, Monique S Neves2, Francisco C F Lobato2, Odir A Dellagostin1, Fabricio R Conceição3.   

Abstract

Cattle botulism is a fatal intoxication caused by botulinum neurotoxins (BoNTs) produced by Clostridium botulinum serotypes C and D resulting in economic losses. Vaccination is the most effective way to control botulism. However, the commercially available vaccines are difficult and hazardous to produce. Neutralizing antibodies against the C-terminal fragment of the BoNT heavy chain (HC) are known to protect against lethal doses of BoNTs. We report the vaccination of cattle with a previously tested recombinant chimera consisting of Escherichia coli heat-labile enterotoxin B subunit and the HC of BoNTs C and D. Vaccinated animals produced neutralizing antibodies against serotypes C and D averaging 5±0 and 6.14±1.06IU/mL, respectively. For BoNT D, the titers were greater than those measured for the commercial vaccine, which induced titers of 5±0 and 2.85±1.35 against the respective serotypes, suggesting that this chimera is effective against cattle botulism.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Botulinum neurotoxins; Clostridium botulinum; Fused antigens; LTB; Recombinant vaccine

Mesh:

Substances:

Year:  2013        PMID: 24252701     DOI: 10.1016/j.vaccine.2013.11.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Formaldehyde effects on kanamycin resistance gene of inactivated recombinant Escherichia coli vaccines.

Authors:  Rafael A Donassolo; Marcos Roberto A Ferreira; Clóvis Moreira; Lucas M Dos Santos; Emili Griep; Gustavo M S G Moreira; Rafael R Rodrigues; Ângela N Moreira; Fabricio R Conceição
Journal:  Biotechnol Lett       Date:  2020-06-04       Impact factor: 2.461

2.  Molecular Evolutionary Constraints that Determine the Avirulence State of Clostridium botulinum C2 Toxin.

Authors:  A Prisilla; R Prathiviraj; P Chellapandi
Journal:  J Mol Evol       Date:  2017-04-05       Impact factor: 2.395

3.  Recombinant Escherichia coli Cell Lysates as a Low-Cost Alternative for Vaccines Against Veterinary Clostridial Diseases.

Authors:  Clóvis Moreira; Gustavo Marçal Schmidt Garcia Moreira; Rafael Amaral Donassolo; Marcos Roberto Alves Ferreira; Mariliana Luiza Ferreira Alves; Rafael Rodrigues Rodrigues; Fabricio Rochedo Conceição
Journal:  Methods Mol Biol       Date:  2022

4.  Humoral Response of Buffaloes to a Recombinant Vaccine against Botulism Serotypes C and D.

Authors:  Denis Y Otaka; José D Barbosa; Clóvis Moreira; Marcos R A Ferreira; Carlos E P Cunha; Antônio R S Brito; Rafael A Donassolo; Ângela N Moreira; Fabrício R Conceição; Felipe M Salvarani
Journal:  Toxins (Basel)       Date:  2017-09-22       Impact factor: 4.546

5.  Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins.

Authors:  Avishai Lublin; Chen Katz; Nady Gruzdev; Itamar Yadid; Itai Bloch; Yigal Farnoushi; Luba Simanov; Asaf Berkowitz; Dalia Elyahu; Jacob Pitcovski; Ehud Shahar
Journal:  Vaccine       Date:  2021-12-30       Impact factor: 3.641

6.  Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.

Authors:  Gustavo Marçal Schmidt Garcia Moreira; Felipe Masiero Salvarani; Carlos Eduardo Pouey da Cunha; Marcelo Mendonça; Ângela Nunes Moreira; Luciana Aramuni Gonçalves; Prhiscylla Sadanã Pires; Francisco Carlos Faria Lobato; Fabricio Rochedo Conceição
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379

7.  Parenteral adjuvant potential of recombinant B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  Carlos Eduardo Pouey da Cunha; Clóvis Moreira; Andréa da Silva Ramos Rocha; Paula Fonseca Finger; Carolina Georg Magalhães; Marcos Roberto Alves Ferreira; Odir Antônio Dellagostin; Ângela Nunes Moreira; Fabricio Rochedo Conceição
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-12       Impact factor: 2.743

Review 8.  Vaccines against Botulism.

Authors:  Grace Sundeen; Joseph T Barbieri
Journal:  Toxins (Basel)       Date:  2017-09-02       Impact factor: 4.546

9.  Immunogenicity of a Bivalent Non-Purified Recombinant Vaccine against Botulism in Cattle.

Authors:  Clóvis Moreira; Marcos R A Ferreira; Carlos E P da Cunha; Rafael A Donassolo; Paula F Finger; Gustavo M S G Moreira; Denis Y Otaka; Loise A de Sousa; José D Barbosa; Ângela N Moreira; Felipe M Salvarani; Fabricio R Conceição
Journal:  Toxins (Basel)       Date:  2018-09-20       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.